Anti-adipocyte monoclonal antibody - Cambridge Antibody Technology/ObeSys
Alternative Names: Human anti-adipocyte monoclonal antibody - Cambridge Antibody Technology/ObeSysLatest Information Update: 07 Jul 1999
At a glance
- Originator Cambridge Antibody Technology; ObeSys
- Class Monoclonal antibodies; Obesity therapies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Obesity
Most Recent Events
- 07 Jul 1999 Discontinued-Preclinical for Obesity in United Kingdom (Unknown route)
- 07 Jul 1999 Discontinued-Preclinical for Obesity in USA (Unknown route)
- 09 Apr 1998 Preclinical development for Obesity in United Kingdom (Unknown route)